Shanghai HeartCare Medical Technology Corporation Limited (06609) released its monthly return on movements in securities for the period ended 28 February 2026. The announcement shows no changes to the issuer’s authorised or registered share capital, which remained at 38.83 million shares. Of these, 31.57 million are H shares, and 7.27 million are unlisted shares, all at a par value of RMB 1.

The total issued H shares stood at 31.57 million, comprising 30.59 million outstanding shares and 0.97 million treasury shares. Unlisted shares remained at 7.27 million, with no changes reported. The public float requirement was confirmed to be in compliance with the 25% threshold. No warrants, convertibles, or other share issuance agreements were disclosed for the reporting period.